President and Chief Executive Officer · Werewolf Therapeutics, Inc. (HOWL)

Daniel Hicklin

A named executive officer of Werewolf Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,545,599

Salary $608,237Stock awards $0Bonus $364,638

FY2023: $1,366,904

1st of 3 named executive officers at Werewolf Therapeutics by FY2024 total.

3 named officers on file for Werewolf Therapeutics, FY2024

Daniel Hicklin’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Werewolf Therapeutics’s whole pay program stands against its peers

  • Werewolf Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HOWL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Daniel Hicklin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Daniel Hicklin compensation by year

Werewolf Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Werewolf Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$583,440$608,237
Bonus$332,561$364,638
Stock awards$0$0
Option awards$438,640$1,559,867
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$12,263$12,857
Total$1,366,904$2,545,599

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Werewolf Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001140361-25-015885, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Werewolf Therapeutics, Inc. filed document, accession 0001140361-25-015885. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$1.4M
$2.5M
FY23
FY24
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option12,952—$16.00
Option58,470—$11.55
Option335,313—$4.64
Option153,907—$2.05

Per the Outstanding Equity Awards at Fiscal Year-End table in Werewolf Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Werewolf Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Daniel Hicklin · this pagePresident and Chief Executive Officer$2,545,599
Randi IsaacsChief Medical Officer$1,440,024
Timothy TrostChief Financial Officer and Treasurer$1,216,560

The full Werewolf Therapeutics compensation record

free company brief

This page is one person within Werewolf Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Werewolf Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Daniel Hicklin's compensation dossier · One-time report. No refunds.